1
|
Durán Reyes G, Rosales AM and Hicks Gómez
JJ: Participation of the follicular fluid in follicular
development, oocyte maturation and spermatic function. Ginecol
Obstet Mex. 65:349–356. 1997.(In Spanish). PubMed/NCBI
|
2
|
Hammadeh ME, Ertan AK, Zeppezauer M,
Baltes S, Georg T, Rosenbaum P and Schmidt W: Immunoglobulins and
cytokines level in follicular fluid in relation to etiology of
infertility and their relevance to IVF outcome. Am J Reprod
Immunol. 47:82–90. 2002.PubMed/NCBI View Article : Google Scholar
|
3
|
Lédée N, Petitbarat M, Rahmati M,
Dubanchet S, Chaouat G, Sandra O, Perrier-d'Hauterive S, Munaut C
and Foidart JM: New pre-conception immune biomarkers for clinical
practice: Interleukin-18, interleukin-15 and TWEAK on the
endometrial side, G-CSF on the follicular side. J Reprod Immunol.
88:118–123. 2011.PubMed/NCBI View Article : Google Scholar
|
4
|
Vercammen M, Verloes A, Haentjens P and
Van de Velde H: Can soluble human leucocyte antigen-G predict
successful pregnancy in assisted reproductive technology? Curr Opin
Obstet Gynecol. 21:285–290. 2009.PubMed/NCBI View Article : Google Scholar
|
5
|
Hammadeh ME, Fischer-Hammadeh C, Amer AS,
Rosenbaum P and Schmidt W: Relationship between cytokine
concentration in serum and preovulatory follicular fluid and in
vitro fertilization/intracytoplasmic sperm injection outcome. Chem
Immunol Allergy. 88:80–97. 2005.PubMed/NCBI View Article : Google Scholar
|
6
|
Ovayolu A, Özdamar Ö, Gün İ, Arslanbuğa
CY, Kutlu T, Tunalı G and Uluhan R: The assesment of follicular
fluid presepsin levels in poor ovarian responder womenandits
relationship with the reproductive outcomes. Int J Clin Exp Med.
8:9961–9966. 2015.PubMed/NCBI
|
7
|
Mehta BN, Chimote MN, Chimote NN, Nath NM
and Chimote NM: Follicular-fluid anti-Mullerian hormone (FF AMH) is
a plausible biochemical indicator of functional viability of oocyte
in conventional in vitro fertilization (IVF) cycles. J Hum Reprod
Sci. 6:99–105. 2013.PubMed/NCBI View Article : Google Scholar
|
8
|
Sallam HN, Sallam NH and Sallam SH:
Non-invasive methods for embryo selection. Facts Views Vis Obgyn.
8:87–100. 2016.PubMed/NCBI
|
9
|
Koo YA, Lee B, Park HJ, Choi J, Lee E and
Choi D: Altered vascular endothelial growth factor expression
during GnRH antagonist protocol in women of reproductive age with
normal baseline hormone profiles. Fertil Steril. 91:744–748.
2009.PubMed/NCBI View Article : Google Scholar
|
10
|
Li M, Bullock CM, Knauer DJ, Ehlert FJ and
Zhou QY: Identification of two prokineticin cDNAs: Recombinant
proteins potently contract gastrointestinal smooth muscle. Mol
Pharmacol. 59:692–698. 2001.PubMed/NCBI View Article : Google Scholar
|
11
|
Matsumoto S, Yamazaki C, Masumoto KH,
Nagano M, Naito M, Soga T, Hiyama H, Matsumoto M, Takasaki J,
Kamohara M, et al: Abnormal development of the olfactory bulb and
reproductive system in mice lacking prokineticin receptor PKR2.
Proc Natl Acad Sci USA. 103:4140–4145. 2006.PubMed/NCBI View Article : Google Scholar
|
12
|
Tu LH, Yu LL, Xiong CL and Zhang HP:
Potential role of prokineticin 2 in experimental varicoceleinduced
rat testes. Urology. 80:952.e15–19. 2012.PubMed/NCBI View Article : Google Scholar
|
13
|
Kim KH, Oh DS, Jeong JH, Shin BS, Joo BS
and Lee KS: Follicular blood flow is a better predictor of the
outcome of in vitro fertilization-embryo transfer than follicular
fluid vascular endothelial growth factor and nitric oxide
concentrations. Fertil Steril. 82:586–592. 2004.PubMed/NCBI View Article : Google Scholar
|
14
|
LeCouter J, Kowalski J, Foster J, Hass P,
Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller
GA, et al: Identification of an angiogenic mitogen selective for
endocrine gland endothelium. Nature. 412:877–884. 2001.PubMed/NCBI View
Article : Google Scholar
|
15
|
Lin R, LeCouter J, Kowalski J and Ferrara
N: Characterization of endocrine gland-derived vascular endothelial
growth factor signaling in adrenal cortex capillary endothelial
cells. J Biol Chem. 277:8724–8729. 2002.PubMed/NCBI View Article : Google Scholar
|
16
|
Kisliouk T, Friedman A, Klipper E, Zhou
QY, Schams D, Alfaidy N and Meidan R: Expression pattern of
prokineticin 1 and its receptors in bovine ovaries during the
estrous cycle: Involvement in corpus luteum regression and
follicular atresia. Biol Reprod. 76:749–758. 2007.PubMed/NCBI View Article : Google Scholar
|
17
|
Lee KF, Lee YL, Chan RW, Cheong AW, Ng EH,
Ho PC and Yeung WS: Up-regulation of endocrine gland-derived
vascular endothelial growth factor but not vascular endothelial
growth factor in human ectopic endometriotic tissue. Fertil Steril.
93:1052–1060. 2010.PubMed/NCBI View Article : Google Scholar
|
18
|
Kisliouk T, Levy N, Hurwitz A and Meidan
R: Presence and regulation of endocrine gland vascular endothelial
growth factor/prokineticin-1 and its receptors in ovarian cells. J
Clin Endocrinol Metab. 88:3700–3707. 2003.PubMed/NCBI View Article : Google Scholar
|
19
|
Alfaidy N, Hoffmann P, Gillois P,
Gueniffey A, Lebayle C, Garçin H, Thomas-Cadi C, Bessonnat J,
Coutton C, Villaret L, et al: PROK1 level in the follicular
microenvironment: A new noninvasive predictive biomarker of embryo
implantation. J Clin Endocrinol Metab. 101:435–444. 2016.PubMed/NCBI View Article : Google Scholar
|
20
|
Brouillet S, Hoffmann P, Chauvet S,
Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ and
Alfaidy N: Revisiting the role of hCG: New regulation of the
angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci.
69:1537–1550. 2012.PubMed/NCBI View Article : Google Scholar
|
21
|
Gao MZ, Zhao XM, Lin Y, Sun ZG and Zhang
HQ: Effects of EG-VEGF, VEGF and TGF-β1 on pregnancy outcome in
patients undergoing IVF-ET treatment. J Assist Reprod Genet.
29:1091–1096. 2012.PubMed/NCBI View Article : Google Scholar
|
22
|
Visser JA and Themmen AP: Anti-Müllerian
hormone and folliculogenesis. Mol Cell Endocrinol. 234:81–86.
2005.PubMed/NCBI View Article : Google Scholar
|
23
|
Fanchin R, Louafi N, Méndez Lozano DH,
Frydman N, Frydman R and Taieb J: Per-follicle measurements
indicate that anti-müllerian hormone secretion is modulated by the
extent of follicular development and luteinization and may reflect
qualitatively the ovarian follicular status. Fertil Steril.
84:167–173. 2005.PubMed/NCBI View Article : Google Scholar
|
24
|
Qin Y, Zhao Z, Sun M, Geng L, Che L and
Chen ZJ: Association of basal serum testosterone levels with
ovarian response and in vitro fertilization outcome. Reprod Biol
Endocrinol. 9(9)2011.PubMed/NCBI View Article : Google Scholar
|
25
|
Hassan AMA, Kotb MMM, AwadAllah AMA,
Shehata NAA and Wahba A: Follicular sensitivity index (FSI): A
novel tool to predict clinical pregnancy rate in IVF/ICSI cycles. J
Assist Reprod Genet. 34:1317–1324. 2017.PubMed/NCBI View Article : Google Scholar
|
26
|
La Marca A, Grisendi V, Giulini S, Argento
C, Tirelli A, Dondi G, Papaleo E and Volpe A: Individualization of
the FSH starting dose in IVF/ICSI cycles using the antral follicle
count. J Ovarian Res. 6(11)2013.PubMed/NCBI View Article : Google Scholar
|
27
|
Kolibianakis EM, Venetis CA,
Kalogeropoulou L, Papanikolaou E and Tarlatzis BC: Fixed versus
flexible gonadotropin-releasing hormone antagonist administration
in in vitro fertilization: A randomized controlled trial. Fertil
Steril. 95:558–562. 2011.PubMed/NCBI View Article : Google Scholar
|
28
|
Huang X, Hao C, Shen X, Liu X, Shan Y,
Zhang Y and Chen L: Differences in the transcriptional profiles of
human cumulus cells isolated from MI and MII oocytes of patients
with polycystic ovary syndrome. Reproduction. 145:597–608.
2013.PubMed/NCBI View Article : Google Scholar
|
29
|
Vural F, Vural B, Doğer E, Çakıroğlu Y and
Çekmen M: Perifollicular blood flow and its relationship with
endometrial vascularity, follicular fluid EG-VEGF, IGF-1, and
inhibin-a levels and IVF outcomes. J Assist Reprod Genet.
33:1355–1362. 2016.PubMed/NCBI View Article : Google Scholar
|
30
|
Ruiz de Assín R, Clavero A, Gonzalvo MC,
Ramírez JP, Zamora S, Fernández A, Martínez L and Castilla JA:
Comparison of methods to determine the assigned value in an
external quality control programme for embryo evaluation. Reprod
Biomed Online. 19:824–829. 2009.PubMed/NCBI View Article : Google Scholar
|
31
|
Nardo LG, Gelbaya TA, Wilkinson H, Roberts
SA, Yates A, Pemberton P and Laing I: Circulating basal
anti-Mullerian hormone levels as predictor of ovarian response in
women undergoing ovarian stimulation for in vitro fertilization.
Fertil Steril. 92:1586–1593. 2009.PubMed/NCBI View Article : Google Scholar
|
32
|
Rodgers RJ and Irving-Rodgers HF:
Formation of the ovarian follicular antrum and follicular fluid.
Biol Reprod. 82:1021–1029. 2010.PubMed/NCBI View Article : Google Scholar
|
33
|
Fraser HM, Bell J, Wilson H, Taylor PD,
Morgan K, Anderson RA and Duncan WC: Localization and
quantification of cyclic changes in the expression of endocrine
gland vascular endothelial growth factor in the human corpus
luteum. J Clin Endocrinol Metab. 90:427–434. 2005.PubMed/NCBI View Article : Google Scholar
|
34
|
Durlinger AL, Visser JA and Themmen AP:
Regulation of ovarian function: The role of anti-Mullerian hormone.
Reproduction. 124:601–609. 2002.PubMed/NCBI View Article : Google Scholar
|
35
|
Kosmas IP, Kolibianakis EM and Devroey P:
Association of estradiol levels on the day of hCG administration
and pregnancy achievement in IVF: A systematic review. Hum Reprod.
19:2446–2453. 2004.PubMed/NCBI View Article : Google Scholar
|
36
|
Yu Ng EH, Yeung WS, Yee Lan Lau E, So WW
and Ho PC: High serum oestradiol concentrations in fresh IVF cycles
do not impair implantation and pregnancy rates in subsequent
frozen-thawed embryo transfer cycles. Hum Reprod. 15:250–255.
2000.PubMed/NCBI View Article : Google Scholar
|
37
|
Kanakkaparambil R, Singh R, Li D, Webb R
and Sinclair KD: B-vitamin and homocysteine status determines
ovarian response to gonadotropin treatment in sheep. Biol Reprod.
80:743–752. 2009.PubMed/NCBI View Article : Google Scholar
|